Document Detail

Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
MedLine Citation:
PMID:  23358177     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: The objective of this study was to explore the clinical significance of survivin expression in epithelial ovarian cancer (EOC) and the effect of survivin small hairpin RNA (shRNA) on survivin expression, apoptosis, and chemosensitivity in the human ovarian cancer cell line OVCAR3.
METHODS: A retrospective review of 90 consecutive EOC patients with a median follow-up time of 51 months was conducted. Survivin expression was examined by immunohistochemistry. OVCAR3 cells were transfected in vitro with survivin shRNA. Survivin mRNA expression levels were detected using reverse transcription-polymerase chain reaction. Flow cytometry was applied to determine survivin protein expression levels and cell apoptotic rates. The MTT method was used to examine the effects of survivin shRNA on chemosensitivity in OVCAR3 cells.
RESULTS: Positive cytoplasmic expression of survivin was associated with advanced International Federation of Gynecology and Obstetrics (FIGO) stage, nonmucinous type, high grade, and recurrence. Positive survivin expression was also associated with platinum resistance (r = 0.306, P = 0.003). Statistical results indicated that FIGO stage (hazard rate = 1.649, P = 0.047) and cytoplasmic expression of survivin (hazard rate = 1.734, P = 0.010) were independent prognostic factors. Survivin mRNA and protein levels were lower in OVCAR3S (ovarian cancer cells transfected with a survivin recombinant vector) cells at 24 hours after transfection as compared with controls. The flow cytometric analysis revealed that survivin shRNA induced accumulation of cells in the G0/Gl phase, with a decrease in G2/M phase cells following 24 hours of culture as compared with a nontransfected group (P < 0.01). Furthermore, survivin shRNA increased the sensitivity of OVCAR3 cells to paclitaxel 15-fold (P < 0.05), whereas it had no significant effect on cisplatin (P > 0.05).
CONCLUSIONS: In addition to FIGO stage, cytoplasmic survivin protein expression is an independent molecular marker for predicting EOC prognosis. Sequence-specific shRNA targeting survivin can effectively suppress survivin expression, enhance apoptosis, and increase the sensitivity of ovarian cancer cells to paclitaxel but not to cisplatin.
Lifeng Chen; Lizhi Liang; Xiaojian Yan; Naihua Liu; Lihua Gong; Shishi Pan; Feng Lin; Qian Zhang; Hongqin Zhao; Feiyun Zheng
Related Documents :
24977327 - Galectin-4 expression is associated with reduced lymph node metastasis and modulation o...
19245807 - Cellular dynamics of the negative transcription elongation factor nelf.
23551867 - Screening pigs for xenotransplantation: prevalence and expression of porcine endogenous...
23671727 - Pparγ agonist-induced alterations in Δ6-desaturase and stearoyl-coa desaturase 1: rol...
16959947 - Molecular mechanisms involved in the adaptive regulation of human intestinal biotin upt...
16978197 - Cytoplasmic localization of p63 is associated with poor patient survival in lung adenoc...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society     Volume:  23     ISSN:  1525-1438     ISO Abbreviation:  Int. J. Gynecol. Cancer     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111626     Medline TA:  Int J Gynecol Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  256-63     Citation Subset:  IM    
*Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang; †Department of Gynecology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong; and ‡Department of Pharmacy, Wenzhou Medical College, Wenzhou, Zhejiang, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Enhancement of withstanding pressure of fibrin sealant by modified mixing ratio of fibrin sealant co...
Next Document:  Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federatio...